Serum eosinophilic cationic protein (ECP) and soluble low affinity receptor for IgE (Fc ( RII/sCD23) concentrations were measured in relation to symptommedication scores, pulmonary function, and total IgE levels in 27 chronic allergic asthmatic children (17 boys, 10 girls), mean age 10.8 years, before and at the end of a three month inhaled corticosteroid (budesonide) treatment period. Serum ECP and sCD23 concentrations were also measured in age matched non-asthmatic controls with allergic rhinitis. All asthma patients had significantly higher serum ECP and sCD23 than the controls, whereas the mean serum 
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STATISTICAL ANALYSIS
For within group comparisons, the Wilcoxon matched pairs signed ranks test was used. For comparisons between asthma and control groups the Mann-Whitney U test was applied. Spearman's rank correlation analysis was used for correlations.
Results
Twenty seven asthmatic children (17 boys, 10 girls), mean age 10.8, SD 2.4 years, range 7.5 to 15.0 years, mean asthma duration 5.6 (2.0) years, completed the study. Two children were excluded from the study group because of non-compliance and failure to complete the symptom diaries. Fifteen healthy nonasthmatic children (12 boys, three girls), mean age 12.0 (1.8) years, range 9.0 to 14.5 years, with perennial allergic rhinitis were recruited as a control group. All children were allergic to three or more inhalant allergens as determined by skin prick testing and RAST. The most common allergens were house dust mite and grass pollens. At the end of the treatment, the mean symptom and medication scores were significantly reduced (p<0.01, p<0.001). the same indices.4 However, it is known that these variables are not always objective indicators. In a recent study that was performed on adult patients with asthma, worsening of symptoms occurred without significant deterioration in pulmonary function tests in 45% of patients. In 10% of the patients there was a fall in pulmonary function, although they were not aware of any change in their symptoms. A relation between the asthma symptoms and pulmonary function tests was found in only 45% of the patients.7 Therefore, in clinical practice it was suggested that in addition to pulmonary function testing, asthma symptoms, bronchodilator requirement, and inflammatory markers must also be evaluated.2 8 9 In a recent report it was shown that ECP concentration was increased in both allergic asthma and intrinsic asthma patients.'0 Similarly, there was no difference in sCD23 levels between allergic and non-allergic children after 3 years of age." Thus it is emphasised in published reports that sCD23 and ECP concentrations, particularly in bronchial asthma, are useful as markers of disease rather than of allergy as such.2 112 As in other studies, the concentrations of sCD23 and ECP in asthmatic children were found to be higher than in non-asthmatic children with allergic rhinitis in our study. In allergic rhinitis the target tissue is smaller than in asthma so the markers of inflammation may not be detected in the peripheral blood. At entry, although our asthmatic children were asymptomatic they had higher concentrations of sCD23 and ECP than non-asthmatic children. This finding suggests subclinical Total IgE concentrations did not decrease with inhaled steroid therapy in our patients and there was no correlation between IgE and sCD23 concentrations before and after the treatment. In patients undergoing bone marrow transplantation, sCD23 concentrations increase initially, followed several days later by a rise in total IgE. This indicates that these two variables do not increase concomitantly. '7 Despite there being no change in IgE levels with inhaled steroid therapy, sCD23 concentrations decreased significantly. In an in vitro investigation, the pharmacological modulation of the CD23 expression on monocytes was investigated. Corticosteroids (dexamethasone or betamethasone) inhibited in a dose and time dependent manner the interleukin-4 induced CD23 expression on human monocytes. In contrast to corticosteroids, ketotifen did not alter the same reaction. 2 Agonists potentiated the interleukin-4 induced CD23 expression.'8 While a weak correlation was found between the improvement in the symptom-medication scores and the reduction in sCD23 levels, no correlation was found with pulmonary function tests in our study. Hoeger et al '" showed a weak correlation between sCD23 levels and asthma severity in asthmatic children older than 10 years, while there was no significant relation in younger children. weeks with topical corticosteroids decreased the numbers of activated eosinophils in, respectively, the bronchial and nasal mucosa of these patients. In many studies, serum ECP has shown a definite correlation with a disease in activity of asthma.9 20 However, this has not been the case in all studies.2' 24 A significant correlation was observed between the reduction of symptom-medication scores with improvement in pulmonary function tests and the decrease in ECP concentrations in our patients
In conclusion, our results show that inhaled corticosteroids decrease the concentrations of both ECP and sCD23 in serum, presumably by inhibiting inflammation in the airways. Monitoring of serum inflammation markers, particularly ECP, may be useful in the follow up of asthmatic children on anti-inflammatory treatment.
